New Business Partnership For Guiding Microchimerism to Transplant Diagnostics with DigitalTRACE™

07/04/2022

Omixon is pleased to announce that we have been entered a new strategic partnership of JETA Molecular BV., based in Utrecht, The Netherlands, effective as of April 2022. This partnership will combine Omixon’s expertise as an international provider of disruptive transplant diagnostics solutions with JETA Molecular latest technological solutions aimed...

ASHI 2021 47th Hybrid Annual Meeting Orlando, Florida, US

24/09/2021

We would like to inform you that the ASHI 2021 Annual Meeting will be a hybrid conference taking place from Sept 27 to Oct 1, in Orlando, FL. Omixon is thrilled to be sponsoring and attending at the 47th ASHI Annual Meeting with a Golden Sponsorship in 2021. We are...

Let’s Get Together at ASHI 2021!

24/09/2021

Let’s Meet Live at ASHI Omixon Booth #211 We are excited to exhibit again at ASHI 2021 between 27th September – 1st October in Orlando, (Florida, US). Our colleagues cannot wait to meet, catch up, and share knowledge with the attendees. We have a couple of special news, activities and games with special...

New Distributor – Biosistemi Grupa d.o.o.

31/05/2021

We are thrilled to announce that Omixon has entered a new distributor partnership with Biosistemi Grupa d.o.o., based in Zagreb, Croatia. Biosistemi was founded in 1989 under the name Analitika d.o.o. as an exclusive distributor of Perkin Elmer, one of the leading manufacturers of analytical laboratory equipment. As the molecular...

Non-Classical HLA-E and what we know to date

31/05/2021

The non-classical major histocompatibility complex (MHC) class I molecules is one of the emerging fields being studied in the last decade. The non-classical class Ib (HLA-Ib) molecules include HLA-E, HLA-F, HLA-G, and HLA-H. These non-classical HLA-Ib molecules, including HLA-E, have a more restricted polymorphism pattern, in comparison to the classical...